AMYRIS TO HOST FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS CONFERENCE CALL ON MARCH 15, 2023

Rhea-AI Summary

Amyris, Inc. (Nasdaq: AMRS) announced it will release its financial results for the fourth quarter and full year ended December 31, 2022, on March 15, 2023, post-market close. CEO John Melo and CFO Han Kieftenbeld will lead a conference call at 1:30 p.m. PT (4:30 p.m. ET) to discuss the results and provide a business update. Participants can access the call via the company's Investor Relations website or by phone at (844) 850-0551.

Amyris focuses on sustainable health and beauty products and holds a proprietary Lab-to-Market™ technology, serving over 300 million consumers through more than 20,000 products.

EMERYVILLE, Calif., Feb. 28, 2023 /PRNewswire/ -- Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company accelerating the world's transition to sustainable consumption through its Lab-to-Market™ technology platform and clean beauty consumer brands, today announced that it will issue its financial results for the fourth quarter and full year ended December 31, 2022, on the afternoon of Wednesday, March 15, 2023, after closing of the financial markets.

The company will hold a conference call and webcast at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time), during which, John Melo, President and Chief Executive Officer, and Han Kieftenbeld, Chief Financial Officer, will discuss Amyris' financial results and provide an update on the company's business. Participants may access the live webcast on Amyris' Investor Relations website, where it will be archived for 90 days. The live call can be accessed by dialing (844) 850-0551 (domestic) or (412) 902-4203 (international) and asking to join the Amyris, Inc. call.

About Amyris
Amyris (Nasdaq: AMRS) is a leading synthetic biotechnology company, transitioning the Clean Health & Beauty and Flavors & Fragrances markets to sustainable ingredients through fermentation and the company's proprietary Lab-to-Market™ technology platform. This Amyris platform leverages state-of-the-art machine learning, robotics and artificial intelligence, enabling the company to rapidly bring new innovation to market at commercial scale. Amyris ingredients are included in over 20,000 products from the world's top brands, reaching more than 300 million consumers. Amyris also owns and operates a family of consumer brands that is constantly evolving to meet the growing demand for sustainable, effective and accessible products. For more information, please visit http://www.amyris.com. 

Amyris, the Amyris logo, and Lab-to-Market are trademarks or registered trademarks of Amyris, Inc. or its subsidiaries in the U.S. and/or other countries.

View original content to download multimedia:https://www.prnewswire.com/news-releases/amyris-to-host-fourth-quarter-and-full-year-2022-financial-results-conference-call-on-march-15-2023-301757841.html

SOURCE Amyris, Inc.

FAQ

When will Amyris release its fourth quarter and full year 2022 financial results?

Amyris will release its financial results on March 15, 2023, after market close.

What time is the conference call for Amyris' financial results?

The conference call will take place at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) on March 15, 2023.

Who will speak during the Amyris conference call?

CEO John Melo and CFO Han Kieftenbeld will discuss the financial results during the call.

How can I access the live webcast of the Amyris conference call?

The live webcast can be accessed on Amyris' Investor Relations website and will be archived for 90 days.